Sector Update: Healthcare Shares Slipping in Pre-Bell

By
A A A

Healthcare stocks:

JNJ: -0.25%

PFE: -0.83%


ABT: -0.06%

MRK: -0.65%

AMGN: -0.51%

Healthcare shares are lower in pre-market, while PDL BioPharma, Inc. ( PDLI ) said it agreed to provide $60 million in debt financing to LENSAR, Inc., a leader in next-generation femtosecond laser technology for refractive cataract surgery.

The financing is part of a package that will see a total of $87 million go to Lensar.

In exchange, PDL received a security interest in all of Lensar's assets and will receive interest on the principal amount outstanding.

PDLI is flat pre-bell in a 52-week range of $6.50 - $8.48.

And, Response Genetics ( RGDX ), which makes molecular diagnostic tests that help determine a patient's response to cancer therapy, said it agreed to join Fortified Provider Network's network of preferred providers. RGDX is flat at $3.32 in pre-market.

The accord gives about 4.1 million members associated with over 200 health insurers, access Response Genetics' suite of molecular predictive testing at a discounted rate. No financial terms of the accord were provided.



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.

Copyright (C) 2014 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.


This article appears in: Investing , Commodities

Referenced Stocks: PDLI , RGDX

MT Newswires

MT Newswires

More from MT Newswires:

Related Videos

Stocks

Referenced

Most Active by Volume

33,974,386
  • $17.98 ▲ 0.28%
20,763,901
  • $91.29 ▲ 2.06%
19,110,793
  • $7.26 ▼ 1.22%
18,528,869
    $8.33 unch
18,014,920
  • $4.19 ▼ 1.18%
16,448,919
  • $25.83 ▼ 0.19%
14,748,190
  • $7.60 ▼ 1.43%
14,144,383
  • $112.01 ▼ 0.47%
As of 12/24/2014, 02:12 PM


Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com